CONTACT US
Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Today, we kick off the monthlong campaign to bring awareness to the importance of considering a clinical trial at diagnosis and during every treatment decision. Stay tuned as we share stories of people who have participated in pancreatic cancer clinical trials and talk to experts about current trends and innovative trials.
In the fight against pancreatic cancer, clinical trials are critical. They give patients early access to cutting-edge treatments that can lead to progress in research and better outcomes.
Every treatment available today was approved through a clinical trial – a research study that investigates new treatments or combinations of existing treatments to determine if they are beneficial to people living with pancreatic cancer.
For pancreatic cancer patients, clinical trials often provide the best outcomes. PanCAN strongly recommends clinical trials at diagnosis and during every treatment decision.
This month, during Pancreatic Cancer Clinical Trials Awareness Month, PanCAN will be talking to experts about the importance of patient diversity in clinical research as well as dispelling common myths. We’ll also be sharing stories from pancreatic cancer patients who have had success on clinical trials.
“I think everyone should consider a clinical trial if they’re eligible,” said Dr. Ira Sharp, a pancreatic cancer survivor who participated in a Phase 1 clinical trial. “The potential payoff is enormous.”
PanCAN is a leader in the pancreatic cancer field. Not only do we maintain the most comprehensive and up-to-date database of pancreatic cancer clinical trials available in the United States, we are a sponsor for Precision PromiseSM, a groundbreaking clinical trial accelerating new treatment options for pancreatic cancer patients.
PanCAN Patient Services can help patients and families understand clinical trials and learn more about their options. PanCAN strongly recommends all patients get genetic testing for inherited mutations and biomarker testing of their tumor tissue to determine if there are treatment options that align with their biology. This testing helps to generate a list of clinical trials that could be a fit based on a patient’s specific needs.
“I come from a background where the philosophers say if you save a life, you’ve saved an entire world,” Ira said. “I believe that. Research and clinical trials are the key to finding better treatments.”
Saving lives…saving an entire world.
Clinical trials offer promise of a brighter future, bringing progress and improving outcomes for pancreatic cancer patients.
